查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1808326

醫療外骨骼市場按組件、類型、技術、功能、結構、操作模式、應用和最終用途分類－2025-2030 年全球預測

Medical Exoskeleton Market by Component, Type, Technology, Functionality, Structure, Mode of Operation, Application, End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2024年醫療外骨骼市場價值將達到16.6億美元，2025年將成長至18.7億美元，到2030年將達到34.2億美元，複合年成長率為12.78%。

主要市場統計數據
基準年2024年 16.6億美元
預計2025年 18.7億美元
預測年份 2030 34.2億美元
複合年成長率（%） 12.78%

醫療外骨骼的革命性進步開啟了醫療保健領域病患行動和臨床復健策略的新時代

醫療外骨骼是生物力學、機器人技術和材料科學的完美融合，為患者和醫護人員提供前所未有的輔助和復健支援。透過整合穿戴式框架和先進的控制系統，這項技術能夠增強人體的力量、耐力和運動能力。其結果不僅顯著改善了神經和肌肉骨骼疾病患者的生活品質，也提升了臨床和工業環境中專業人員的工作能力。

醫療外骨骼技術的動態變化透過跨學科創新重新定義動態支撐，提升使用者體驗

隨著跨學科技術的融合，醫療外骨骼的模式正在發生變革，以克服歷史性挑戰。如今，自適應控制演算法利用機器學習模型即時預測步態模式，實現與人體自然運動的無縫同步。同時，笨重的框架正被輕質複合材料和軟性電子設備所取代，從而提高了使用者的舒適度和便攜性。

評估美國關稅改革對醫療外骨骼產業供應鏈和全球競爭的連鎖反應

美國近期實施的關稅調整已波及整個醫療外骨骼供應鏈，促使製造商重新評估籌資策略和成本結構。曾經從現有供應商進口且經濟實惠的零件如今面臨關稅上調，迫使相關人員在非關稅管轄區尋找替代供應商。因此，一些公司正在加快近岸外包步伐，以保持價格競爭力並確保關鍵硬體的供應。

揭示構成醫療外骨骼生態系的組件、應用等關鍵細分洞察

從組件構成的角度審視市場，可以發現兩個主要領域：硬體部分，包括致動器、微控制器和感測器等關鍵元件；軟體部分，透過控制模組和監控平台提供功能。這種二元性凸顯了具體機械框架與控制運動並提供性能分析的智慧系統之間的相互依賴性。

區域展望：重點介紹美洲、歐洲、中東和非洲以及亞太地區醫療外骨骼產業的成長動力和挑戰

區域動態正在塑造各主要地區不同的成長軌跡和應用模式。美洲地區在完善的報銷框架和鼓勵復健技術創新的政府獎勵的推動下，發展勢頭強勁。行業領導者正在透過與臨床卓越中心合作檢驗療效，增強機構信任並推動採購舉措。

夥伴關係透過策略夥伴關係、技術創新和市場差異化改變醫療外骨骼發展的先鋒組織

醫療外骨骼領域的主要企業透過內部研發能力和策略夥伴關係的結合，脫穎而出。一些知名的設備創新者已投入大量資金建立跨職能研發中心，以促進快速原型製作和迭代設計週期。這些中心匯集了工程師、臨床醫生和使用者體驗專家，以改善產品人體工學並確保臨床有效性。

克服監管複雜性並推動醫療外骨骼市場永續成長的策略行動計劃

行業相關人員必須優先開發支援第三方應用程式整合和資料交換的互通平台。這種對開放式架構的重視將催生一個廣泛的治療和診斷工具生態系統，改善臨床結果，並促進其在各個醫療機構的採用。此外，投資於允許逐步升級的模組化設計可以縮短更換週期，促進永續發展。

結合一手資料和二手資料以及嚴謹的分析調查方法，以檢驗醫學外骨骼研究的見解。

該研究框架整合了透過與臨床專家、設備製造商和關鍵意見領袖進行結構化訪談收集的一手資訊，以確保獲得關於性能屬性和採用障礙的第一手見解。二次研究包括對監管備案文件、科學出版物、專利資料庫、行業白皮書等的廣泛研究綜述，以建立堅實的依證。

總結性結論強調了指導未來醫療外骨骼創新和應用發展的關鍵趨勢的影響和策略重要性

先進機械結構、智慧控制系統和整合感測器網路的出現，推動醫療外骨骼從小眾原型發展成為變革性的醫療保健解決方案。這種融合正在重新定義復健模式，增強患者獨立性，並拓展神經和整形外科應用的治療可能性。同時，自適應經營模式正在透過將硬體與軟體和服務結合，強化價值提案。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章市場動態

  • 人工智慧演算法整合用於復健計劃中的自適應外骨骼輔助
  • 輕質複合材料和模組化設計提高了外骨骼患者的舒適度和移動性
  • 醫療外骨骼Start-Ups公司與大型醫療保健組織合作擴大臨床試驗
  • 具有遠端監控功能的遠距復健平台在醫療外骨骼治療中的出現
  • 電池技術和無線控制系統的進步將延長外骨骼在臨床環境中的運作時間
  • 監管部門的核准和現代報銷框架增加了醫療外骨骼治療方法的可及性
  • 整合外骨骼系統和虛擬實境環境，實現沉浸身臨其境型神經復健和病人參與
  • 利用 3D 掃描和積層製造客製化外骨骼設計，加速患者個人化貼合
  • 擴展遠距復健平台，為中風患者提供遠距外骨骼訓練
  • 在家庭醫療保健環境中，使用軟性機器人外骨骼協助老年人行動的現象正在增加

第6章 市場洞察

  • 波特五力分析
  • PESTEL分析

第7章：2025年美國關稅的累積影響

8. 醫療外骨骼市場（依組件）

  • 硬體
    • 致動器
    • 微控制器
    • 感應器
  • 軟體
    • 控制軟體
    • 監控軟體

第9章 醫療外骨骼市場（按類型）

  • 被動外骨骼
  • 動力外骨骼

第 10 章醫療外骨骼市場（按技術）

  • 電
  • 油壓
  • 機器
  • 氣壓

第11章醫療外骨骼市場（按功能）

  • 全身外骨骼
  • 下半身外骨骼
  • 上身外骨骼

第12章 醫療外骨骼市場結構分析

  • 硬外骨骼
  • 軟外骨骼

第13章 醫療外骨骼市場（依運動方式）

  • 自主外骨骼
  • 手動控制
  • 半自動/輔助

第14章醫療外骨骼市場（按應用）

  • 助行輔助器具
    • 殘疾患者
    • 老年人支持
  • 診斷支持
  • 復原
  • 手術援助
  • 治療用途
    • 整形外科復健
    • 物理治療

15. 醫療外骨骼市場（依最終用途）

  • 養老設施
  • 居家照護環境
  • 軍事/國防
  • 科學研究院所及大學
  • 運動與健身

16.美洲醫療外骨骼市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

17.歐洲、中東和非洲醫療外骨骼市場

  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 阿拉伯聯合大公國
  • 沙烏地阿拉伯
  • 南非
  • 丹麥
  • 荷蘭
  • 卡達
  • 芬蘭
  • 瑞典
  • 奈及利亞
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波蘭
  • 瑞士

18. 亞太地區醫療外骨骼市場

  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 印尼
  • 泰國
  • 菲律賓
  • 馬來西亞
  • 新加坡
  • 越南
  • 台灣

第19章 競爭態勢

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • B-Temia Inc.
    • Comau SpA
    • Cyberdyne Inc.
    • Ekso Bionics Holdings Inc.
    • ExoAtlet, LLC
    • Focal Meditech BV
    • Honda Motor Co. Ltd.
    • Hyundai Motor Company
    • Levitate Technologies, Inc.
    • Lockheed Martin Corporation
    • Mitsubishi Heavy Industries, Ltd.
    • Myomo, Inc.
    • Ottobock SE & Co. KGaA
    • P&S Mechanics Co., Ltd.
    • Panasonic Holdings Corporation
    • Parker Hannifin Corporation
    • ReWalk Robotics Ltd.
    • Rex Bionics Plc
    • Roam Robotics
    • Toyota Motor Corporation
    • Trexo Robotics, Inc.
    • Wandercraft SAS
    • Yaskawa Electric Corporation

第20章 研究人工智慧

第21章 研究統計

第22章 研究聯絡人

第23章 研究報導

第24章 附錄

Product Code: MRR-3E32260F820F

The Medical Exoskeleton Market was valued at USD 1.66 billion in 2024 and is projected to grow to USD 1.87 billion in 2025, with a CAGR of 12.78%, reaching USD 3.42 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 1.66 billion
Estimated Year [2025] USD 1.87 billion
Forecast Year [2030] USD 3.42 billion
CAGR (%) 12.78%

Revolutionary Advances in Medical Exoskeletons Charting a New Era of Patient Mobility and Clinical Rehabilitation Strategies Across Healthcare Settings

Medical exoskeletons represent a remarkable convergence of biomechanics, robotics, and materials science, offering patients and practitioners unprecedented levels of assistance and rehabilitation support. By integrating wearable frameworks with sophisticated control systems, this technology amplifies human strength, endurance, and mobility. The result is a tangible improvement in quality of life for individuals coping with neurological or musculoskeletal impairments, as well as enhanced capabilities for professionals in clinical and industrial environments.

Transitioning from conceptual prototypes to commercial products has been driven by collaborative efforts among research institutions, healthcare providers, and technology companies. Advances in sensor accuracy, actuator efficiency, and software intelligence support adaptive motion control and real-time monitoring. This synergy is enabling personalized therapies that gradually restore functionality and independence. Furthermore, the integration of telemetric data collection facilitates outcome tracking and remote clinical oversight, which broadens the potential for home-based rehabilitation and long-term care.

This executive summary delves into the key dynamics shaping the medical exoskeleton domain, examining emerging innovations, policy influences, and segmentation landscapes. It offers a comprehensive view of how evolving requirements and technological frontiers are converging to redefine patient outcomes and foster new market opportunities across healthcare and allied sectors.

Dynamic Transformations in Medical Exoskeleton Technology Redefining Biomechanical Support and Enhancing User Experience Through Interdisciplinary Innovation

The landscape of medical exoskeletons is undergoing transformative shifts as multidisciplinary technologies integrate to overcome historical challenges. Adaptive control algorithms now leverage machine learning models that predict gait patterns in real time, enabling seamless synchronization with natural human movement. Concurrently, lightweight composite materials and flexible electronics have replaced bulkier frameworks, enhancing user comfort and portability.

Beyond hardware refinements, the emergence of cloud-connected platforms is redefining post-deployment engagement. Clinicians and engineers can collaboratively assess performance metrics and adjust therapeutic regimens from remote locations. This connectivity not only accelerates the innovation cycle but also fosters iterative improvements based on real-world feedback. Regulatory bodies are responding by streamlining approval pathways for devices that demonstrate robust safety profiles and consistent clinical efficacy.

Moreover, strategic alliances between medtech firms and academic research centers are unlocking novel functionalities. From exoskeletons with haptic feedback modules to integrated biosensing arrays, the ecosystem is expanding to address specialized applications such as neurological diagnostics and surgical assistance. Together, these shifts are steering the industry toward a future in which medical exoskeletons become integral components of personalized care plans and rehabilitative protocols.

Assessing the Ripple Effects of Recent United States Tariff Reforms on the Medical Exoskeleton Industry Supply Chain and Global Competitive Positioning

Recent tariff adjustments implemented by the United States have reverberated throughout the medical exoskeleton supply chain, prompting manufacturers to revisit sourcing strategies and cost structures. Components that were once economically imported from established suppliers now face increased duties, leading stakeholders to explore alternative suppliers in non-tariff jurisdictions. As a result, some companies have accelerated nearshoring initiatives to maintain price competitiveness and secure critical hardware access.

In response to higher landed costs, manufacturers have optimized product architectures to reduce dependency on expensive imported subsystems. This has spurred in-house development of custom microcontroller boards and actuator assemblies, while software modules increasingly rely on open-source platforms to curb licensing expenses. Such adaptations have preserved profit margins, but they also demand heightened investment in quality assurance and compliance protocols.

Conversely, extended lead times for certain sensor components have underscored the need for diversified supplier networks. Firms are forging collaborative partnerships with regional contract manufacturers to mitigate disruption risk and improve responsiveness. Amid these adjustments, effective inventory management practices and dynamic procurement models have emerged as essential tactics for cushioning against future tariff fluctuations and ensuring uninterrupted production cycles.

Deep Dive into Market Segmentation Revealing Essential Insights from Components to Applications Shaping the Medical Exoskeleton Ecosystem

Examining the market through the lens of component composition reveals two primary domains: a hardware segment, which encompasses critical elements such as actuators, microcontrollers, and sensors, and a software segment that delivers functionality via control modules and monitoring platforms. This duality underscores the interdependence between tangible mechanical frameworks and the intelligent systems that orchestrate movement and provide performance analytics.

When evaluating device typologies, passive exoskeletons offer structural support without powered augmentation, whereas powered exoskeletons deliver active force generation to augment user exertion. Each modality meets distinct clinical and operational objectives, shaping end-user preferences and integration strategies. Diverse technological architectures further influence device behavior, whether through electric actuators that provide precise motion control, hydraulic systems that deliver robust force output, mechanical linkages that capitalize on energy storage, or pneumatic structures that offer adjustable compliance.

Functional classifications extend across full body designs, which support comprehensive mobility, lower body configurations targeting gait assistance, and upper body systems dedicated to limb rehabilitation. The structural paradigm may follow rigid exoskeleton frameworks that offer maximal stability or soft exosuits that enhance comfort and adaptability. Modes of operation range from fully autonomous units that execute preprogrammed gait cycles to manually controlled units guided by therapist input, with semi-autonomous variants blending assisted responsiveness with voluntary user commands.

Applications span a spectrum including assistive devices for mobility-customized for disabled patients or tailored toward elderly assistance-diagnostic support in movement assessment, rehabilitation regimens focused on neurorehabilitation, surgical assistance for orthopedic interventions, and therapeutic use in orthopedic recovery and physical therapy contexts. Finally, end-use settings encompass specialized elderly care facilities, in-home healthcare environments, military and defense training venues, research institutions and universities, as well as sports and fitness applications where performance augmentation and injury prevention converge.

Regional Perspectives Unveil Growth Drivers and Challenges Across the Americas Europe Middle East & Africa and Asia-Pacific in the Medical Exoskeleton Sector

Regional dynamics are shaping divergent growth trajectories and adoption patterns across key geographies. In the Americas, significant momentum is generated by well-established reimbursement frameworks and government incentives that encourage innovation in rehabilitation technologies. Industry leaders are collaborating with clinical centers of excellence to validate efficacy, thereby reinforcing institutional confidence and driving procurement initiatives.

Meanwhile, the Europe, Middle East & Africa corridor benefits from harmonized regulatory guidelines that streamline cross-border device approvals. Strong academic collaboration networks and public-private partnerships stimulate research and pilot deployments, particularly in countries with advanced healthcare infrastructure. Emerging markets within this region are experiencing a gradual uptick in demand as governments invest in modernizing caregiving facilities and expanding home-based care programs.

In the Asia-Pacific arena, demographic trends such as aging populations and a rising prevalence of mobility-related conditions are catalyzing demand for assistive technologies. Local manufacturers are establishing joint ventures with global technology firms to bridge gaps in technical know-how and accelerate commercialization. As regulatory authorities refine medical device frameworks, the pathway to market is becoming more navigable, further supporting the introduction of next-generation exoskeleton systems.

Profiling Pioneering Organizations Transforming Medical Exoskeleton Development Through Strategic Partnerships Technological Breakthroughs and Market Differentiation

Leading organizations in the medical exoskeleton domain are distinguishing themselves through a combination of internal research capabilities and strategic alliances. Some prominent device innovators have invested heavily in cross-functional R&D centers to foster rapid prototyping and iterative design cycles. These hubs bring together engineers, clinicians, and user experience specialists to refine product ergonomics and ensure clinical efficacy.

Partnership models have also emerged as pivotal drivers of competitive differentiation. By aligning with sensor manufacturers, software developers, and academic research institutions, key companies can integrate specialized technologies such as advanced biosensors or predictive analytics engines without diluting core competencies. Such ecosystems facilitate scalable manufacturing processes and accelerate regulatory approvals by leveraging collective expertise.

Moreover, market leaders are enhancing their value propositions through service offerings that complement hardware sales. This includes comprehensive training modules for healthcare providers, subscription-based software updates, and remote monitoring packages that deliver continuous performance insights. These value-added solutions not only foster customer loyalty but also generate recurring revenue streams, reinforcing long-term financial stability.

Strategic Action Plans Empowering Leaders to Seize Opportunities Navigate Regulatory Complexities and Drive Sustainable Growth in the Medical Exoskeleton Market

Industry stakeholders must prioritize the development of interoperable platforms that support third-party application integration and data exchange. This emphasis on open architectures will catalyze a broader ecosystem of therapeutic and diagnostic tools, enhancing clinical outcomes and driving adoption across care settings. Additionally, investing in modular designs that allow incremental upgrades can reduce replacement cycles and promote sustainable growth.

Navigating complex regulatory landscapes requires a proactive engagement strategy with governing bodies. By participating in standard-setting committees and contributing to clinical evidence generation, companies can expedite approval processes and influence policy frameworks in their favor. Simultaneously, cultivating relationships with patient advocacy groups will strengthen market acceptance and ensure that product roadmaps align with genuine user needs.

Operational resilience hinges on diversified supply chain networks and adaptive procurement models. Leaders should explore near-term sourcing alternatives and establish contingency plans to mitigate tariff impacts and component shortages. At the same time, comprehensive training and certification programs for end users will enhance device utilization rates, reduce liability concerns, and foster trust among healthcare professionals.

Comprehensive Methodological Framework Combining Primary Intelligence Secondary Research and Analytical Rigor to Validate Insights in the Medical Exoskeleton Research

The research framework integrates primary intelligence gathered through structured interviews with clinical experts, device manufacturers, and key opinion leaders, ensuring firsthand insights into performance attributes and adoption barriers. Secondary research constitutes an extensive review of regulatory filings, scientific publications, patent databases, and industry white papers, establishing a robust evidence base.

To validate qualitative findings, a rigorous triangulation methodology has been employed. This process cross-verifies information from diverse sources, including academic journals, conference proceedings, and technology roadmaps. Quantitative data is subjected to consistency checks against multiple proprietary and publicly accessible databases to ensure reliability.

Furthermore, an expert panel comprising biomedical engineers, rehabilitation therapists, and regulatory consultants reviewed preliminary conclusions to mitigate bias and enhance analytical depth. Data synthesis involved thematic analysis and scenario mapping to capture emerging trends, technological inflection points, and potential market disruptions. The result is a comprehensive, transparent, and replicable approach that underpins the integrity of the insights presented.

Synthesized Conclusions Highlighting Key Trends Implications and Strategic Imperatives Guiding the Future Trajectory of Medical Exoskeleton Innovation and Adoption

The advent of advanced mechanical structures, intelligent control systems, and integrated sensor networks has propelled medical exoskeletons from niche prototypes to transformative healthcare solutions. This convergence is redefining rehabilitation paradigms, bolstering patient independence, and expanding therapeutic possibilities across neurologic and orthopedic applications. Meanwhile, adaptive business models are strengthening the value proposition by coupling hardware with software and services.

Regional and segment-specific nuances underscore the importance of tailored strategies. Manufacturers that align product development with localized regulatory requirements and end-user expectations will be best positioned to capture emerging opportunities. Collaboration remains paramount, as cross-industry alliances are accelerating the translation of research breakthroughs into clinically validated offerings.

Looking ahead, the trajectory of medical exoskeleton technology hinges on fostering ecosystem interoperability, optimizing cost structures, and demonstrating long-term patient outcomes. As stakeholders navigate evolving policy landscapes and supply chain complexities, strategic agility and evidence-based decision making will determine market leadership and sustainable impact in this rapidly maturing sector.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Integration of artificial intelligence algorithms for adaptive exoskeleton assistance in rehabilitation programs
  • 5.2. Adoption of lightweight composite materials and modular designs to enhance patient comfort and mobility in exoskeleton devices
  • 5.3. Strategic partnerships between medical exoskeleton startups and major healthcare providers for clinical trial expansion
  • 5.4. Emergence of tele-rehabilitation platforms with remote monitoring capabilities in medical exoskeleton treatments
  • 5.5. Advancements in battery technology and wireless control systems to extend exoskeleton operational duration in clinical settings
  • 5.6. Regulatory approvals and updated reimbursement frameworks driving increased accessibility of medical exoskeleton therapies
  • 5.7. Integration of virtual reality environments with exoskeleton systems for immersive neurorehabilitation and patient engagement
  • 5.8. Customization of exoskeleton design through 3D scanning and additive manufacturing accelerating patient-specific fit
  • 5.9. Expansion of tele-rehabilitation platforms incorporating remote-controlled exoskeleton training for stroke patients
  • 5.10. Surge in soft robotic exosuit adoption for elderly mobility support in home healthcare settings

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Medical Exoskeleton Market, by Component

  • 8.1. Introduction
  • 8.2. Hardware
    • 8.2.1. Actuators
    • 8.2.2. Microcontrollers
    • 8.2.3. Sensors
  • 8.3. Software
    • 8.3.1. Control Software
    • 8.3.2. Monitoring Software

9. Medical Exoskeleton Market, by Type

  • 9.1. Introduction
  • 9.2. Passive Exoskeletons
  • 9.3. Powered Exoskeletons

10. Medical Exoskeleton Market, by Technology

  • 10.1. Introduction
  • 10.2. Electric
  • 10.3. Hydraulic
  • 10.4. Mechanical
  • 10.5. Pneumatic

11. Medical Exoskeleton Market, by Functionality

  • 11.1. Introduction
  • 11.2. Full Body Exoskeletons
  • 11.3. Lower Body Exoskeletons
  • 11.4. Upper Body Exoskeletons

12. Medical Exoskeleton Market, by Structure

  • 12.1. Introduction
  • 12.2. Rigid Exoskeletons
  • 12.3. Soft Exoskeletons

13. Medical Exoskeleton Market, by Mode of Operation

  • 13.1. Introduction
  • 13.2. Autonomous Exoskeletons
  • 13.3. Manual Controlled
  • 13.4. Semi Autonomous/Assisted

14. Medical Exoskeleton Market, by Application

  • 14.1. Introduction
  • 14.2. Assistive Devices for Mobility
    • 14.2.1. Disabled Patients
    • 14.2.2. Elderly Assistance
  • 14.3. Diagnostic Support
  • 14.4. Rehabilitation
  • 14.5. Surgical Assistance
  • 14.6. Therapeutic Use
    • 14.6.1. Orthopedic Recovery
    • 14.6.2. Physical Therapy

15. Medical Exoskeleton Market, by End-Use

  • 15.1. Introduction
  • 15.2. Elderly Care Facilities
  • 15.3. Homecare Settings
  • 15.4. Military & Defense
  • 15.5. Research Institutions & Universities
  • 15.6. Sports & Fitness

16. Americas Medical Exoskeleton Market

  • 16.1. Introduction
  • 16.2. United States
  • 16.3. Canada
  • 16.4. Mexico
  • 16.5. Brazil
  • 16.6. Argentina

17. Europe, Middle East & Africa Medical Exoskeleton Market

  • 17.1. Introduction
  • 17.2. United Kingdom
  • 17.3. Germany
  • 17.4. France
  • 17.5. Russia
  • 17.6. Italy
  • 17.7. Spain
  • 17.8. United Arab Emirates
  • 17.9. Saudi Arabia
  • 17.10. South Africa
  • 17.11. Denmark
  • 17.12. Netherlands
  • 17.13. Qatar
  • 17.14. Finland
  • 17.15. Sweden
  • 17.16. Nigeria
  • 17.17. Egypt
  • 17.18. Turkey
  • 17.19. Israel
  • 17.20. Norway
  • 17.21. Poland
  • 17.22. Switzerland

18. Asia-Pacific Medical Exoskeleton Market

  • 18.1. Introduction
  • 18.2. China
  • 18.3. India
  • 18.4. Japan
  • 18.5. Australia
  • 18.6. South Korea
  • 18.7. Indonesia
  • 18.8. Thailand
  • 18.9. Philippines
  • 18.10. Malaysia
  • 18.11. Singapore
  • 18.12. Vietnam
  • 18.13. Taiwan

19. Competitive Landscape

  • 19.1. Market Share Analysis, 2024
  • 19.2. FPNV Positioning Matrix, 2024
  • 19.3. Competitive Analysis
    • 19.3.1. B-Temia Inc.
    • 19.3.2. Comau S.p.A.
    • 19.3.3. Cyberdyne Inc.
    • 19.3.4. Ekso Bionics Holdings Inc.
    • 19.3.5. ExoAtlet, LLC
    • 19.3.6. Focal Meditech BV
    • 19.3.7. Honda Motor Co. Ltd.
    • 19.3.8. Hyundai Motor Company
    • 19.3.9. Levitate Technologies, Inc.
    • 19.3.10. Lockheed Martin Corporation
    • 19.3.11. Mitsubishi Heavy Industries, Ltd.
    • 19.3.12. Myomo, Inc.
    • 19.3.13. Ottobock SE & Co. KGaA
    • 19.3.14. P&S Mechanics Co., Ltd.
    • 19.3.15. Panasonic Holdings Corporation
    • 19.3.16. Parker Hannifin Corporation
    • 19.3.17. ReWalk Robotics Ltd.
    • 19.3.18. Rex Bionics Plc
    • 19.3.19. Roam Robotics
    • 19.3.20. Toyota Motor Corporation
    • 19.3.21. Trexo Robotics, Inc.
    • 19.3.22. Wandercraft S.A.S.
    • 19.3.23. Yaskawa Electric Corporation

20. ResearchAI

21. ResearchStatistics

22. ResearchContacts

23. ResearchArticles

24. Appendix

LIST OF FIGURES

  • FIGURE 1. MEDICAL EXOSKELETON MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2024 VS 2030 (%)
  • FIGURE 16. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 18. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2024 VS 2030 (%)
  • FIGURE 20. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 22. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 24. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 27. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 28. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 29. MEDICAL EXOSKELETON MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. MEDICAL EXOSKELETON MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 31. MEDICAL EXOSKELETON MARKET: RESEARCHAI
  • FIGURE 32. MEDICAL EXOSKELETON MARKET: RESEARCHSTATISTICS
  • FIGURE 33. MEDICAL EXOSKELETON MARKET: RESEARCHCONTACTS
  • FIGURE 34. MEDICAL EXOSKELETON MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. MEDICAL EXOSKELETON MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY ACTUATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY ACTUATORS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY MICROCONTROLLERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY MICROCONTROLLERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY SENSORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY SENSORS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY CONTROL SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY CONTROL SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY MONITORING SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY MONITORING SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY PASSIVE EXOSKELETONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY PASSIVE EXOSKELETONS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY POWERED EXOSKELETONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY POWERED EXOSKELETONS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY ELECTRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY ELECTRIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY HYDRAULIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY HYDRAULIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY MECHANICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY MECHANICAL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY PNEUMATIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY PNEUMATIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY FULL BODY EXOSKELETONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY FULL BODY EXOSKELETONS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY RIGID EXOSKELETONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY RIGID EXOSKELETONS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY SOFT EXOSKELETONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY SOFT EXOSKELETONS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY AUTONOMOUS EXOSKELETONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY AUTONOMOUS EXOSKELETONS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY MANUAL CONTROLLED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY MANUAL CONTROLLED, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY SEMI AUTONOMOUS/ASSISTED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY SEMI AUTONOMOUS/ASSISTED, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY DISABLED PATIENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY DISABLED PATIENTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY ELDERLY ASSISTANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY ELDERLY ASSISTANCE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY DIAGNOSTIC SUPPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY DIAGNOSTIC SUPPORT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY REHABILITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY REHABILITATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY SURGICAL ASSISTANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY SURGICAL ASSISTANCE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY ORTHOPEDIC RECOVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY ORTHOPEDIC RECOVERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 87. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 89. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2025-2030 (USD MILLION)
  • TABLE 91. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2025-2030 (USD MILLION)
  • TABLE 93. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY ELDERLY CARE FACILITIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY ELDERLY CARE FACILITIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 95. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 97. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY MILITARY & DEFENSE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY MILITARY & DEFENSE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 99. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY RESEARCH INSTITUTIONS & UNIVERSITIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY RESEARCH INSTITUTIONS & UNIVERSITIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 101. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY SPORTS & FITNESS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY SPORTS & FITNESS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 103. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 104. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 105. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
  • TABLE 106. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2025-2030 (USD MILLION)
  • TABLE 107. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 108. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 109. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 110. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 111. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 112. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 113. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 114. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 115. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2024 (USD MILLION)
  • TABLE 116. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2025-2030 (USD MILLION)
  • TABLE 117. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 118. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2025-2030 (USD MILLION)
  • TABLE 119. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 120. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 121. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2018-2024 (USD MILLION)
  • TABLE 122. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2025-2030 (USD MILLION)
  • TABLE 123. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2018-2024 (USD MILLION)
  • TABLE 124. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2025-2030 (USD MILLION)
  • TABLE 125. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2024 (USD MILLION)
  • TABLE 126. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2025-2030 (USD MILLION)
  • TABLE 127. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 129. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 130. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 131. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
  • TABLE 132. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2025-2030 (USD MILLION)
  • TABLE 133. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 134. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 135. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 136. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 137. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 138. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 139. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 140. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 141. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2024 (USD MILLION)
  • TABLE 142. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2025-2030 (USD MILLION)
  • TABLE 143. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 144. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2025-2030 (USD MILLION)
  • TABLE 145. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 146. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 147. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2018-2024 (USD MILLION)
  • TABLE 148. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2025-2030 (USD MILLION)
  • TABLE 149. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2018-2024 (USD MILLION)
  • TABLE 150. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2025-2030 (USD MILLION)
  • TABLE 151. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2024 (USD MILLION)
  • TABLE 152. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2025-2030 (USD MILLION)
  • TABLE 153. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 154. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 155. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 156. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 157. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
  • TABLE 158. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2025-2030 (USD MILLION)
  • TABLE 159. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 160. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 161. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 162. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 163. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 164. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 165. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 166. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 167. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2024 (USD MILLION)
  • TABLE 168. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2025-2030 (USD MILLION)
  • TABLE 169. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 170. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2025-2030 (USD MILLION)
  • TABLE 171. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 172. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 173. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2018-2024 (USD MILLION)
  • TABLE 174. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2025-2030 (USD MILLION)
  • TABLE 175. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2018-2024 (USD MILLION)
  • TABLE 176. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2025-2030 (USD MILLION)
  • TABLE 177. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2024 (USD MILLION)
  • TABLE 178. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2025-2030 (USD MILLION)
  • TABLE 179. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 180. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 181. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
  • TABLE 182. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2025-2030 (USD MILLION)
  • TABLE 183. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 184. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 185. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 186. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 187. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 188. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 189. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 190. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 191. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2024 (USD MILLION)
  • TABLE 192. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2025-2030 (USD MILLION)
  • TABLE 193. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 194. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2025-2030 (USD MILLION)
  • TABLE 195. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 196. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 197. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2018-2024 (USD MILLION)
  • TABLE 198. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2025-2030 (USD MILLION)
  • TABLE 199. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2018-2024 (USD MILLION)
  • TABLE 200. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2025-2030 (USD MILLION)
  • TABLE 201. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2024 (USD MILLION)
  • TABLE 202. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2025-2030 (USD MILLION)
  • TABLE 203. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 204. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 205. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
  • TABLE 206. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2025-2030 (USD MILLION)
  • TABLE 207. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 208. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 209. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 211. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 212. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 213. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 214. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 215. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2024 (USD MILLION)
  • TABLE 216. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2025-2030 (USD MILLION)
  • TABLE 217. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 218. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2025-2030 (USD MILLION)
  • TABLE 219. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 220. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 221. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2018-2024 (USD MILLION)
  • TABLE 222. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2025-2030 (USD MILLION)
  • TABLE 223. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2018-2024 (USD MILLION)
  • TABLE 224. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2025-2030 (USD MILLION)
  • TABLE 225. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2024 (USD MILLION)
  • TABLE 226. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2025-2030 (USD MILLION)
  • TABLE 227. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 228. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 229. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
  • TABLE 230. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2025-2030 (USD MILLION)
  • TABLE 231. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 232. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 233. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 235. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 236. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 237. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 238. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 239. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2024 (USD MILLION)
  • TABLE 240. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2025-2030 (USD MILLION)
  • TABLE 241. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 242. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2025-2030 (USD MILLION)
  • TABLE 243. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 244. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 245. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2018-2024 (USD MILLION)
  • TABLE 246. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2025-2030 (USD MILLION)
  • TABLE 247. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2018-2024 (USD MILLION)
  • TABLE 248. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2025-2030 (USD MILLION)
  • TABLE 249. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2024 (USD MILLION)
  • TABLE 250. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2025-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2025-2030 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2025-2030 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2025-2030 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2025-2030 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2025-2030 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2025-2030 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 278. UNITED KINGDOM MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
  • TABLE 280. UNITED KINGDOM MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2025-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 282. UNITED KINGDOM MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. UNITED KINGDOM MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 285. UNITED KINGDOM MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 286. UNITED KINGDOM MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 287. UNITED KINGDOM MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 288. UNITED KINGDOM MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 289. UNITED KINGDOM MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2024 (USD MILLION)
  • TABLE 290. UNITED KINGDOM MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2025-2030 (USD MILLION)
  • TABLE 291. UNITED KINGDOM MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 292. UNITED KINGDOM MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2025-2030 (USD MILLION)
  • TABLE 293. UNITED KINGDOM MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 294. UNITED KINGDOM MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 295. UNITED KINGDOM MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2018-2024 (USD MILLION)
  • TABLE 296. UNITED KINGDOM MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2025-2030 (USD MILLION)
  • TABLE 297. UNITED KINGDOM MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2018-2024 (USD MILLION)
  • TABLE 298. UNITED KINGDOM MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2025-2030 (USD MILLION)
  • TABLE 299. UNITED KINGDOM MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2024 (USD MILLION)
  • TABLE 300. UNITED KINGDOM MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2025-2030 (USD MILLION)
  • TABLE 301. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 302. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 303. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
  • TABLE 304. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2025-2030 (USD MILLION)
  • TABLE 305. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 306. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 307. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 309. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 310. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 311. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 312. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 313. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2024 (USD MILLION)
  • TABLE 314. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2025-2030 (USD MILLION)
  • TABLE 315. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 316. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2025-2030 (USD MILLION)
  • TABLE 317. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 318. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 319. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2018-2024 (USD MILLION)
  • TABLE 320. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2025-2030 (USD MILLION)
  • TABLE 321. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2018-2024 (USD MILLION)
  • TABLE 322. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2025-2030 (USD MILLION)
  • TABLE 323. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2024 (USD MILLION)
  • TABLE 324. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2025-2030 (USD MILLION)
  • TABLE 325. FRANCE MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 326. FRANCE MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 327. FRANCE MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
  • TABLE 328. FRANCE MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2025-2030 (USD MILLION)
  • TABLE 329. FRANCE MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 330. FRANCE MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 331. FRANCE MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 332. FRANCE MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 333. FRANCE MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 334. FRANCE MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 335. FRANCE MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 336. FRANCE MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (U